Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 2 Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Nasopharyngeal Carcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Cetuximab 14 Cisplatin 12 pembrolizumab 11 Paclitaxel 9 Gemcitabine 9 durvalumab 6 Nivolumab 6 Docetaxel 6 toripalimab 5 Carboplatin 5 Radiotherapy 4 Fluorouracil 4 Cyclophosphamide 4 fludarabine 3 Valproic Acid 3 Capecitabine 3 tremelimumab 2 spartalizumab 2 nimotuzumab 2 irinotecan sucrosofate 2 fludarabine phosphate 2 cemiplimab 2 anlotinib 2 Sunitinib 2 S 1 (combination) 2 Radiation 2 Oxaliplatin 2 NVP-BKM120 2 Methotrexate 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × temoporfin × Head & Neck × Clear all

NCT01086488 2011-07-08

FOSCAN

Ministry of Health, Malaysia

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡